Enanta Pharmaceuticals shares owned by Barclays
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enanta Pharmaceuticals by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $388k | 41k | 9.39 |
2023-09-30 | $193k | 17k | 11.21 |
2023-06-30 | $1.1M | 51k | 21.39 |
2023-03-31 | $1.1M | 26k | 40.45 |
2022-12-31 | $2.4M | 51k | 46.52 |
2022-09-30 | $2.4M | 45k | 51.86 |
2022-06-30 | $274k | 5.8k | 47.27 |
2022-03-31 | $1.1M | 15k | 71.22 |
2021-12-31 | $1.9M | 25k | 74.77 |
2021-09-30 | $1.3M | 23k | 56.82 |
2021-06-30 | $494k | 11k | 44.05 |
2021-03-31 | $1.2M | 24k | 49.31 |
2020-12-31 | $1.0M | 25k | 42.11 |
2020-09-30 | $1.2M | 26k | 45.82 |
2020-06-30 | $903k | 18k | 50.25 |
2020-03-31 | $759k | 15k | 51.40 |
2019-12-31 | $3.0M | 48k | 61.78 |
2019-09-30 | $2.2M | 36k | 60.04 |
2019-06-30 | $3.1M | 37k | 84.42 |
2019-03-31 | $5.4M | 56k | 95.51 |
2018-12-31 | $795k | 11k | 70.77 |
2018-09-30 | $2.4M | 29k | 85.46 |
2018-06-30 | $632k | 5.5k | 115.86 |
2018-03-31 | $654k | 8.1k | 80.75 |
2017-12-31 | $1.6M | 27k | 58.68 |
2017-09-30 | $1.2M | 27k | 46.81 |
2017-06-30 | $1.1M | 30k | 35.69 |
2017-03-31 | $1.8M | 59k | 30.69 |
2016-12-31 | $358k | 11k | 32.89 |
2016-09-30 | $25k | 798 | 30.93 |
2016-06-30 | $9.0k | 375 | 24.00 |
2016-03-31 | $65k | 2.2k | 28.97 |
2015-12-31 | $11k | 382 | 29.94 |
2015-09-30 | $177k | 4.9k | 36.03 |
2015-06-30 | $18k | 368 | 48.39 |
2015-03-31 | $22k | 739 | 29.65 |
2014-12-31 | $45k | 832 | 53.72 |
2014-09-30 | $1.5M | 38k | 39.00 |
2014-06-30 | $3.0M | 69k | 43.00 |
2014-03-31 | $3.1M | 81k | 39.00 |
2013-12-31 | $4.1M | 153k | 27.00 |
2013-09-30 | $4.6M | 207k | 22.00 |
2013-06-30 | $3.2M | 180k | 17.71 |